Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD

Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD

Chronic obstructive pulmonary disease (COPD) is a severely disabling chronic lung disease characterized by persistent airway inflammation, which leads to limited expiratory airflow that deteriorates over time. Isorhamnetin (Iso) is one of the most important active components in the fruit of Hippopha...

Full description

Bibliographic Details
Main Authors: Yifan Xu, Jing Li, Zhiwei Lin, Weiquan Liang, Lijie Qin, Jiabin Ding, Shuqi Chen, Luqian Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Pharmacology
Subjects:
isorhamnetin
COPD
inflammation
Nrf2
keap1
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.860362/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.860362/full

Similar Items